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Background: Sexual function is an essential component of life. For this reason, sexual dysfunction can have a
negative impact on the wellbeing of men and women alike. Since the turn of the 21st century, research on female
sexual dysfunction (FSD) has gained momentum. While FSD is often assessed in people with ill health, sexual
dysfunction is an illness of its own entity and is also prevalent in non-patient populations. A critical review of
current literature on female sexual dysfunction in general populations will shed light on possible determinants as
well as at-risk groups. Thus, the aim of this systematic review is to assess the prevalence and the predictors of
female sexual dysfunction in general populations.
Methods/Design: A systematic review of current literature on FSD will be performed. Studies will be considered for
review if they report quantitative data on the prevalence of female sexual dysfunction. Outcome measures will
include the prevalence of FSD, the time period assessed, and significant predictors for each domain of FSD. The
scientific databases MEDLINE, EMBASE, PsycINFO, and Web of Science will be systematically searched in cooperation
with a medical research librarian. Hand searches for further relevant publications will also be undertaken. Screening
of search results and extraction of data from included studies will be conducted cooperatively by two authors. The
quality of the studies will be appraised and documented. Results will be compiled and presented in evidence
tables.
Discussion: In the past decade, population-based studies on female sexual dysfunction have increased in number
and grown more varied in their cultural settings. This review aims to provide a current overview of the prevalence
of female sexual dysfunction in populations from various countries, cultures, and age groups in order to provide a
better understanding of its effect on women's lives today.
Keywords: Systematic review, Female sexual dysfunction, Sexual disorder, Prevalence, Predictors, General
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Introduction
Sexual function is an essential component of life. For
this reason, sexual dysfunction can have a negative im-
pact on the wellbeing of an individual. According to the
Diagnostic and Statistical Manual of Mental Diseases
(DSM), sexual dysfunction is characterized by a disturb-
ance in the processes that characterize the sexual response
cycle or by pain associated with sexual intercourse [1].
Among women, sexual dysfunction generally falls into
four categories: hypoactive sexual desire disorder, female* Correspondence: megan.mccool@klinik.uni-regensburg.de
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unless otherwise stated.sexual arousal disorder, female orgasm disorder, and pain
disorders [2].
Female sexual dysfunction (FSD) has attracted more
interest in the past few decades [2]. At the turn of the
21st century, FSD was identified as a significant yet
largely uninvestigated public health problem [3]. At the
time, there was little population-based data available
concerning the prevalence, predictors, and consequences
of this disorder [3].
In 2004, West et al. performed a systematic review of
global literature on the prevalence and predictors of FSD
in general populations, starting with studies from 1966
to 2004 [4]. The review identified 40 studies on FSD in
general populations. She examined sexual dysfunction
overall and differentiated it into the four major domains:l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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order, and pain disorders. West et al. encountered two
major challenges in the research: (1) the ever-changing
definitions of sexual disorders limit a comparison across
studies and (2) none of the studies used psychometrically
validated instruments to assess dysfunction [4]. This made
it impossible to provide an overall prevalence of FSD.
West et al. concluded: ‘In all of the research done in this
field to date, none of the studies meet the quality criteria
set for prevalence studies (i.e., a well-defined representa-
tive sample and a validated assessment of female sexual
dysfunction)’ [4].
Since 2004, further studies on FSD have been performed
around the globe in general populations. Therefore, we
see the need for a renewed systematic review of the
current literature on the prevalence of FSD in general
populations. Through this review, we also intend to
identify significant predictors of FSD, as well as the psy-
chometrically validated assessment tools which have
been used to assess FSD.
Previous reviews on FSD in clinical populations
Recent systematic reviews focus on FSD primarily in
clinical populations, for example, in patients with dia-
betes [5], cardiovascular disease [6], psoriasis [7], or
depression [8].
In 2013, Pontiroli et al. established that FSD is indeed
significantly more frequent among women with diabetes
than those without [5]. These were the results of 26
studies which employed the Female Sexual Function
Index (FSFI) by Rosen [9] to measure dysfunction. A low
FSFI score (indicator of dysfunction) was associated with
high body mass index [5].
Another review in 2013 examined sexual dysfunction
in male and female patients with cardiovascular disease.
Based on 24 studies, Nascimento et al. discovered that
among women, all domains of sexual function (desire,
arousal, vaginal lubrication, orgasm, sexual dissatisfaction,
and pain) were affected by the disease [6]. Furthermore,
sexual dysfunction varied according to severity of cardio-
vascular disease [6].
In 2012, Kurizky et al. compiled a review of studies re-
lated to patients (male and female) with psoriasis. A
multilingual search of literature between 1966 and 2011
resulted in only eight eligible studies [7]. Results of the
review revealed a general decline of sexual function
among patients with psoriasis; dysfunction may be influ-
enced by ‘the severity of skin findings, the psychological
effects of the condition on the patient, concerns of the
sexual partner, and side effects of the medical treatment
for psoriasis’ [7]. In addition, results showed that nearly
half of all psoriasis patients lamented that healthcare
professionals did not sufficiently address their sexual
problems [7].Another recent review from 2012 measured the bidir-
ectional association of depression and sexual dysfunction
among men and women [8]. Atlantis and Sullivan
pooled odds ratios or relative risks across studies using
random-effects meta-analysis models [8]. The analysis
confirmed that depression increased the risk of sexual
dysfunction and that sexual dysfunction increased the
odds of depression [8].
Previous reviews on FSD in general population samples
We have identified only two systematic reviews that ad-
dressed FSD in the general population: Spector and Carey
in 1990 [10] and West et al. in 2004 [4].
In Spector and Carey's critical review of 23 studies, the
incidence and prevalence of sexual dysfunction among
men and women were assessed. Incidence was seldom
reported; therefore, the prevalence of dysfunction for men
and women was presented. Due to the limited number of
community studies, prevalence rates in the domains of
FSD varied considerably (female arousal disorder 11%–
48%) or were non-existent (no data on the pain disorder
vaginismus) [10]. However, determinants such as age, edu-
cation, socio-economic status, marital status, and gender
were found to have an influence sexual dysfunction in
men and women [10]. Spector and Carey had three points
of critique: (1) populations were not representative, (2) as-
sessment tools varied considerably, and (3) the definitions
of dysfunction were inconsistent between studies [10].
Thus, recommendations for future research included
‘stratified samples representative of the general population,
the use of psychometrically sound assessment techniques
to facilitate interpretation and replication and finally, a
common classification system to aid comparison across
studies’ [10].
A systematic review by West et al. over 10 years later
highlighted similar study limitations as those reported
by Spector and Carey. West et al. stated that there still
seems to be a lack of data on general populations, since
finding a large representative sample is challenging and
expensive. West et al. reiterated that the varying defini-
tions of dysfunction as well as the lack of standardized,
valid assessment tools present a challenge in comparing
prevalence across studies [4]. Although it was not possible
to provide an overall prevalence of FSD in general popula-
tions, West et al. was able to provide individual prevalence
rates of FSD from 40 international studies, illustrating in-
creased interest in FSD between 1990 and 2004. Further-
more, she identified similar predictors of FSD in general
populations, e.g., age, education, socio-economic status,
and relationship with partner [4]. She also uncovered new
determinants such as physical health (both observed and
perceived), race/ethnicity, emotional condition, number of
premarital partners, religion, sexual orientation, as well as
the rigidity of gender roles in a relationship [4].
McCool et al. Systematic Reviews 2014, 3:75 Page 3 of 5
http://www.systematicreviewsjournal.com/content/3/1/75Rationale
There is substantial justification for a systematic review
of the prevalence and predictors of FSD. First of all, the
most recent systematic literature review is 10 years old,
beckoning a new systematic review of all currently avail-
able literature. Secondly, as indicated by some of West
et al.'s determinants of FSD, the predictors of sexual
dysfunction may vary over time, in response to cultural
shifts, as well as generational and societal norms. Fur-
thermore, within the past few years, first-ever popula-
tion studies have been performed in countries in which
the topic of female sexuality has generally been taboo.
Studies on FSD among Iranian [11,12] or Egyptian
women [13] may provide a valuable contribution to the
global perspective on FSD. Finally, in addition to com-
piling current prevalence rates, analyzing significant
predictors for each domain of FSD will help identify risk
populations within the general population.
Methods/Design
Protocol and registration
The methods for this systematic review have been devel-
oped according to recommendations from the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statements [14]. This protocol has been regis-
tered in the International Prospective Register of Systematic
Reviews (PROSPERO): CRD42014009526.
Objective
This study aims to assess the prevalence and predictors
of FSD among various age groups of women in general
populations
Search strategy
We will begin by developing a comprehensive database
containing all published studies addressing the preva-
lence of FSD in general populations. A systematic search
of MEDLINE, EMBASE, PsycINFO, and Web of Science
will be undertaken. Because our focus is on more recent
studies on FSD, we will examine publications from 2000
to 2014. For a list of terms which will be searched, see
Additional file 1. The systematic search will be performed
in close cooperation with a medical research librarian.
Searches will be limited to studies of humans and to peer-
reviewed full text articles in English. Duplicates will be re-
moved. Additional citations will be located by searching
through conference proceedings (World Meeting on Sexual
Health, Congress of the European Society for Sexual
Medicine). Finally, reference lists will be searched manu-
ally for relevant studies.
Selection criteria
The population of interest will include adult women in
the general population, from menarche to menopause.Cross-sectional, cohort, and case-control studies will be
included in this systematic review. The study should re-
port the prevalence of at least one domain of FSD. There
will be no geographical limitation on the included stud-
ies. Only publications in the English language will be
included.
Study selection
Search results will be imported into Endnote. One re-
viewer will screen titles and abstracts for their potential
relevance. If there is any uncertainty at this stage, the art-
icle will remain included until the full text is reviewed. Ar-
ticles identified through reference lists of included studies
and relevant systematic reviews will be considered for
inclusion on the basis of their title.
Two reviewers (MEM and MAT) will then assess the
full text of all articles identified in the screening process
for potential inclusion. Where information pertinent to
inclusion criteria is not contained within the article text,
the effort will be made to contact the listed correspond-
ing author. Where no reply is received, the article will
be excluded. Consensus between the two authors under-
taking review of the study will need to be reached before
the article is included. Inclusion disagreement will be
discussed and resolved by consensus or arbitration by a
third investigator (CA). A PRISMA flow chart of the
study selection procedure will be prepared, and a log of
rejected studies will be maintained.
Data extraction
Data will be extracted from the included studies using a
pre-designed, pilot-tested electronic data form (Microsoft
Access). The form has been pilot-tested on ten randomly
selected publications on the prevalence and predictors of
FSD. Based on the results of the pilot test, the form was
revised by the authors. Using the electronic form, one re-
view author (MEM) will extract the data from the in-
cluded studies and a second author (MAT) will validate
the extracted data. Disagreements will be resolved by dis-
cussion between the two reviewers; if no agreement can
be reached, consensus will be sought through discussions
with the third author (CA). Data will be extracted on the
following:
1. Publication details: title, journal, author(s), year, city,
and country in which the study was conducted, type
of publication, and source of funding
2. Design: type of study (cross-sectional, cohort,
case-control), aims of study, method of data
collection, response rate, recruitment methods,
eligibility (inclusion and exclusion criteria), name of
assessment tool(s), validation of assessment tool(s)
3. Study participant details: number of persons
interviewed or surveyed, population characteristics
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4. Data for outcome measures: prevalence of FSD, time
period referenced in assessment, significant
predictors for each domain of FSD
5. Limitations: selection bias, response bias,
information bias, limitations of assessment tool(s)
used
Quality assessment
At the time of the review in 2004, West et al. lacked a
tool for assessing the quality of observational studies.
However, evaluation of study quality was based on (1)
how women were recruited and (2) how the information
was obtained. West et al. described that both selection
and information bias had an impact on the results of her
review. For this review, we will use the Newcastle-Ottawa
Scale for the quality assessment of non-randomized stud-
ies [15]. Quality scores will be presented in a table.
Data synthesis
Relevant data extracted from eligible studies will be pre-
sented in evidence tables (see Additional files 2 and 3). A
narrative synthesis will provide a summary of the preva-
lence of FSD according to age, as well as the predictors of
FSD. Limitations of the studies will be discussed in detail.
Implications of the review as well as suggestions for future
research will also be provided.
Discussion
In the past decade, population studies on FSD have in-
creased in number and grown more varied in their cul-
tural setting. The proposed systematic review aims to
provide a current overview of the prevalence of FSD in
general female populations from various countries, cul-
tures, and age groups in order to allow a better under-
standing of its effect on women's lives today.
Strengths and limitations
The strengths of this review include clearly established
purpose, as well as a systematic and transparent approach.
Our search will be performed in close cooperation with a
specialized research librarian with a medical degree; the
screening and extraction will be performed cooperatively
by two researchers employing pretested, standardized ex-
traction forms. Unlike the previous reviews, this review
will provide significant results on the predictors for each
domain of FSD. Furthermore, quality assessment of each
study will be performed and presented in a table. While
the review may include novel studies from a wide variety
of cultures, a limitation of the study is its restriction to
the English language. Despite a predefined systematic
approach, the study will also involve judgments made
by review authors, which can result in bias.Dissemination
Findings will be disseminated through publication in peer-
reviewed journals and conference presentations at relevant
conferences.
Additional files
Additional file 1: Search strategy. Proposed search terms to be used
in the systematic search of literature databases.
Additional file 2: Evidence table. Proposed table for presenting the
extracted data from eligible studies.
Additional file 3: Predictor table. Significant predictors of female
sexual dysfunction.
Abbreviation
FSD: Female sexual dysfunction.
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